Variant report
Variant | esv3376951 |
---|---|
Chromosome Location | chr2:51889920-51890411 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142835097 | chr2:51889934-51889935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370445620 | chr2:51889959-51889960 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112637756 | chr2:51889973-51889974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs13382721 | chr2:51889983-51889984 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530951146 | chr2:51889987-51889988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148354562 | chr2:51890004-51890005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs201661327 | chr2:51890007-51890008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551851618 | chr2:51890051-51890052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570489974 | chr2:51890064-51890065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185429947 | chr2:51890104-51890105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551032053 | chr2:51890105-51890106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189555794 | chr2:51890125-51890126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs28961622 | chr2:51890159-51890160 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs536906154 | chr2:51890201-51890202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555343090 | chr2:51890241-51890242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs966733 | chr2:51890276-51890277 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs537671964 | chr2:51890296-51890297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs28961623 | chr2:51890303-51890304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577232226 | chr2:51890382-51890383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17864572 | chr2:51890395-51890396 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs17864573 | chr2:51890407-51890408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Schizophrenia | 20967226 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51888400-51891800 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr2:51889000-51891200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
3 | chr2:51889200-51890600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr2:51889400-51891200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr2:51889400-51891400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr2:51889600-51890600 | Weak transcription | H9 Cell Line | embryonic stem cell |
7 | chr2:51889600-51890800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
8 | chr2:51889800-51891400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr2:51889800-51892400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |